MARKET

CRMD

CRMD

Cormedix
NASDAQ
12.16
+0.53
+4.56%
After Hours: 12.20 +0.04 +0.33% 19:50 01/02 EST
OPEN
11.81
PREV CLOSE
11.63
HIGH
12.29
LOW
11.74
VOLUME
2.16M
TURNOVER
--
52 WEEK HIGH
17.43
52 WEEK LOW
5.60
MARKET CAP
958.07M
P/E (TTM)
5.92
1D
5D
1M
3M
1Y
5Y
1D
Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio
NASDAQ · 1d ago
AXSM Up on FDA Priority Review to AXS-05 sNDA in Alzheimer's Agitation
NASDAQ · 1d ago
Corcept Tanks on FDA's CRL to Relacorilant NDA in Hypercortisolism
NASDAQ · 1d ago
INSM Stock Up 78% in 6 Months: Here's What You Need to Know
NASDAQ · 1d ago
Here's Why Replimune Stock Skyrockets Nearly 131% in 3 Months
NASDAQ · 12/31/2025 19:42
Here's Why You Should Retain Community Health Stock for Now
NASDAQ · 12/31/2025 16:24
RARE Rises on Completion of Rolling Submission for AAV Gene Therapy
NASDAQ · 12/31/2025 14:50
VNDA Obtains FDA Nod for Motion Sickness Drug, Stock Gains
NASDAQ · 12/31/2025 12:36
More
About CRMD
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product, DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 milligrams per milliliter (mg/mL), and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). The Company is also commercializing a portfolio of anti-infective products including MINOCIN, REZZAYO, VABOMERE, ORBACTIV, BAXDELA, and KIMYRSA, as well as TOPROL-XL.

Webull offers CorMedix Inc stock information, including NASDAQ: CRMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRMD stock methods without spending real money on the virtual paper trading platform.